CME Group Inc. · NASDAQ:CME
CME — Cbot Holdings — Merger or Acquisition (June 2007)
24 slides from CME's merger presentation, Jun 25, 2007
Slide 1: Filed by Chicago Mercantile Exchange Holdings pursuant to Rule 425
Filed by Chicago Mercantile Exchange Holdings Inc. pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-6 under the Securities Exchange Act of 1934, as amended. Subject Company: CBOT Holdings, Inc. Subject Company’s Commission File No.:001-32650
Slide 2: CME/CBOT Merger: The Right Trade for CBOT Members and Shareholders
CME/CBOT MERGER: THE RIGHT TRADE FOR CBOT MEMBERS AND SHAREHOLDERS CME/CBOT MERGER ICE PROPOSAL LONG-TERM POTENTIAL Creates world’s largest and most valuable exchange, best positioned to Combination with niche player does not materially enhance CBOT’s compete and thrive in today’s globally competiti
Slide 3: Setting the Record Straight on the CME/CBOT Merger: Know the Risks of Dealing with ICE
June 25, 2007 SETTING THE RECORD STRAIGHT ON THE CME/CBOT MERGER: KNOW THE RISKS OF DEALING WITH ICE Dear CBOT Shareholders: We are sending this letter to set the record straight and make sure that all CBOT members and shareholders have the facts they need to see through the ICE propaganda and under
Slide 4: ICE Provides a High Risk Proposition
Credit Suisse: “We believe the greatest near-term risk to our ICE call relates to its bid to merge with CBOT. We believe a successful bid would likely lead to sizeable equity issuance/earnings dilution, higher investment spending and integration risk while dampening ICE’s stand-alone high growth fra
Slide 5: Vote YES on a CBOT/CME combination
derivatives product line available via state of the art trading platform or floor. We will have world-class clearing that will continue to provide over $1 billion in margin efficiencies. We will continue our collective tradition of providing preferred pricing for high volume producers. We have regul
Slide 6: CME/CBOT: A Combination to Compete Successfully in the Global Marketplace
CME/CBOT: A Combination to Compete Successfully in the Global Marketplace Presentation to ISS Craig Donohue, CEO
Slide 7: Discussion of Forward-Looking Statements
Discussion of Forward-Looking Statements Forward-Looking Statements This presentation may contain forward-looking information regarding Chicago Mercantile Exchange Holdings Inc. and CBOT Holdings, Inc. and the combined company after the completion of the merger that are intended to be covered by the
Slide 8: Comparison of Price/Earnings Ratios
Comparison of Price/Earnings Ratios ICE’s P/E ratios are out of range from their exchange peers Price/Earnings Ratio 2007 2008 ICE 46.8 32.1 Take over speculations drive NMX 51.2 37.1 price/earnings BOT 42.5 36.1 ratios Historically, CME CME 35.3 27.4 has had a P/E ratio NYSE Euronext 30.9 23.0 high
Slide 9: Value Comparison from an Institutional Shareholder Perspective
Value Comparison from an Institutional Shareholder Perspective On a risk adjusted basis, taking into consideration long term growth opportunities, integration risks and currency risks, CME’s offer is superior CME ICE ICE stock price CME stock price $158.55 $560.00 (06/21/07 close) (tender offer) Imp
Slide 10: Risks to ICE Value
Risks to ICE Value Recent analysts’ concerns “If it became evident ICE would win [CBOT], ICE stock would fall substantially, perhaps to $135 or $140.” ~Mike Vinciquerra, BMO Capital Markets (6/15/07) “We continue to highlight ICE’s merger proposal for CBOT as the greatest near-term risk to our thesi
Slide 11: ICE Stock Price – No Longer Driven by Fundamentals
ICE Stock Price – No Longer Driven by Fundamentals ICE’s stock has take-over premium built into its price ICE implied $220 BOT Spot $200 $180 K G I $160 B C D F ICE Spot A $140 J E H $120 [A] 5/11: CME increases exchange ratio to 0.3500x [G] 6/4: ICE announces acquisition of ChemConnect; record May
Slide 12: ICE's Current Stock Price / Takeover Premium
ICE’s Current Stock Price / Takeover Premium Analysts believe there could be up to a 15% takeover premium in ICE’s stock price Recent analysts’ comments on takeover premium “If it became evident ICE would win [CBOT], ICE stock would fall substantially, perhaps to $135 or $140.” ~Mike Vinciquerra, BM
Slide 13: Currency Risks in NYSE / Euronext Transaction
Currency Risks in NYSE / Euronext Transaction NYX stock has declined by 25% since Euronext shareholders approved transaction.... ($ in millions, except per share amounts) NYX Annotated Stock Price Chart ICE Annotated Stock Price Chart Price Volume Price Volume $120 16,000 $160 Shareholder vote 14,00
Slide 14: CME/CBOT Proposed Merger
CME/CBOT Proposed Merger CME and CBOT will create the largest exchange in the world contracts in 000s Pro Forma Q107 ADV 12,000 10,320 10,000 3,866 8,000 7,295 6,000 4,607 4,000 3,431 6,454 3,866 2,000 1,512 741 0 CBOT/CME Eurex CBOT/ICE Euronext.liffe NYMEX Note: [1] Eurex and Euronext.liffe includ
Slide 15: CME/CBOT Proposed Merger
CME/CBOT Proposed Merger CBOT/CME have much greater presence across all major asset classes and are well positioned to leverage significant new growth opportunities Q1 2007 Combined ADV by Product Line (in 000’s) 8,000 CBOT/CME 8,000 CBOT/ICE 6,671 6,000 6,000 CME ICE CBOT CBOT 4,000 4,000 3,032 2,3
Slide 16: CME Average Daily Volume
CME Average Daily Volume Annual – Long Term Monthly – Short Term (contracts in 000’s) (contracts in 000’s) 52% 8,000 8,000 May07 ADV 6.1M rd 3 highest month 6,358 Jun07 ADV to date 6,000 6,000 9.1M 4,000 74% 4,000 2,000 2,000 917 0% 0 0 00 01 02 03 04 05 06 07 Jan Feb Mar Apr May Jun 07 07 07 07 07
Slide 17: CME's Growth Strategy
CME’s Growth Strategy CME will be the leading global derivatives company by: • Globalizing our business • Being a leading service provider of transaction processing services • Expanding into over-the-counter/spot markets • Leading product and technology innovation © Chicago Mercantile Exchange Inc.
Slide 18: Globalizing Our Business
Globalizing Our Business CME Globex live access from more than 80 countries 7 European/ Asian hubs • Regionally focused sales, education and marketing to key targets • Broadening relationships in emerging markets CME provides access to highly liquid markets across all major asset classes on an indus
Slide 19: Leading Service Provider in Transaction Processing
Leading Service Provider in Transaction Processing Transaction Processing Customer Benefits • Treasuries • Ags • Equities • Metals • Scalable platforms • Advanced functionality • CME customer service standards • Energy • Metals • Broad distribution/network effects • Soft Commodities • Proven integra
Slide 20: NYMEX on CME Globex Leads Electronic Energy Trading
NYMEX on CME Globex Leads Electronic Energy Trading Total Energy ADV 640 (contracts in thousands) 601 480 524 334 320 160 79 NYMEX began trading on CME Globex on June 12, 2006 0 Q206 Q306 Q406 Q107 Q207 ICE Futures NYMEX Energy to date on CME Globex © Chicago Mercantile Exchange Inc. All rights rese
Slide 21: Significant Opportunities In Larger OTC/Spot Markets
Significant Opportunities In Larger OTC/Spot Markets • OTC Foreign Exchange • OTC Interest Rate Swaps $2 Average Daily Turnover trillion $1 trillion $0.5 trillion $0.1 $0.05 trillion trillion Global OTC US US Europe, Middle East Interest Rates Equities & Africa FX Treasuries Equities Source: BIS 200
Slide 22: OTC/Spot Market Opportunities
OTC/Spot Market Opportunities ADV Favorable Market Trends (notional value in millions, USD) $1,350 $1,206 • Electronic $1,200 $1,050 $900 • Centralized clearing $750 $600 $509 • Algorithmic trading $450 $331 $300 • Transparency/anonymity $150 $0 Apr-07 May-07 June-07 MTD • Client acquisition and par
Slide 23: Larger, More Valuable OTC Growth Opportunities
Larger, More Valuable OTC Growth Opportunities CBOT/CME is better positioned to immediately pursue the full scope of OTC growth opportunities $300 $262 trillion $250 CBOT/CME Opportunities $200 ICE $150 Opportunities $100 $38 trillion $50 $20 trillion $7 $6 trillion trillion $0 Interest Rate FX Mark
Slide 24: Summary Timeline
Summary Timeline Original merger agreement - October 17, 2006 ICE offer rejected by CBOT - May 11, 2007 Revised merger agreement - May 11, 2007 DOJ clearance of merger agreement - June 11, 2007 Revised ICE offer rejected - June 14, 2007 CME/CBOT cash dividend and ERP solution adopted - June 14, 2007